Literature DB >> 8003737

Aetiology and pathogenesis of chronic inflammatory bowel disease.

T T MacDonald1, S H Murch.   

Abstract

While Crohn's disease and ulcerative colitis are both conditions characterized by intestinal inflammation, with some overlap in their clinical and histological features, they are essentially different in pathogenesis. Crohn's disease appears to be primarily a condition of chronic T-lymphocyte activation, with tissue damage induced by secondary macrophage activation. What activates the T-cells is unknown. In this chapter we look at the evidence for and against cell-wall deficient mycobacteria species, viral infection of vascular endothelium and luminal contents as potential mechanisms of chronic activation. In ulcerative colitis, by contrast, there is no strong evidence for T-cell activation, and humoral mechanisms predominate. While the finding of atypical anti-neutrophil cytoplasmic antibodies (P-ANCAs) may be useful in screening, the only novel pathogenetic discovery is the co-localization of a 40 kD colonic autoantibody with immunoglobulins and complement on the apical enterocyte surface. Despite the fundamental differences in initiating mechanisms, the two conditions have many 'downstream' inflammatory processes in common. We discuss the evidence for local production of cytokines, arachidonic acid metabolites and reactive oxygen and nitrogen radicals, highlighting the potential adverse consequences for intestinal vascular integrity.

Entities:  

Mesh:

Year:  1994        PMID: 8003737     DOI: 10.1016/s0950-3528(06)80017-5

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  11 in total

1.  Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?

Authors:  Alnoor Ramji; David A Owen; Siegfried R Erb; Charles H Scudamore; Eric M Yoshida
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 2.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Immunoprotective Effect of Probiotic Dahi Containing Lactobacillus acidophilus and Bifidobacterium bifidum on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice.

Authors:  Sagar R Jadhav; Umesh Kr Shandilya; Vinod K Kansal
Journal:  Probiotics Antimicrob Proteins       Date:  2012-03       Impact factor: 4.609

4.  An unusual presentation of fistulating Crohn's disease: Ascites.

Authors:  Richard Kia; David White; Sanchoy Sarkar
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

5.  Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.

Authors:  J Meenan; J Spaans; T A Grool; S T Pals; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

Review 6.  Inflammatory myositis in association with inflammatory bowel disease.

Authors:  A Kulkarni; T J Ravi; G J Brodmerkel; R M Agrawal
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.487

Review 7.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

8.  Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis.

Authors:  Yong-Deok Jeon; Keuk-Soo Bang; Min-Kyoung Shin; Jong-Hyun Lee; Young-Nam Chang; Jong-Sik Jin
Journal:  BMC Complement Altern Med       Date:  2016-11-16       Impact factor: 3.659

9.  Beneficial effect of Amorphophallus paeoniifolius tuber on experimental ulcerative colitis in rats.

Authors:  Yadu Nandan Dey; Garima Sharma; Manish M Wanjari; Dharmendra Kumar; Vinay Lomash; Ankush D Jadhav
Journal:  Pharm Biol       Date:  2016-09-07       Impact factor: 3.503

10.  Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease.

Authors:  Jayanti P Behera; Bisweswar Mohanty; Y Roja Ramani; Bandana Rath; Supriya Pradhan
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.